Methods of biochemical diagnosis early stage of Parkinson’s disaese in Uzbekistan
Objective: The purpose of our study was the early diagnosis of detection of Parkinson's disease using biochemical markers. Background: In recent years, due to the…Montreal Cognitive Assessment cutoff point for cognitive impairment in Mexican subjects with PD: A neuropsychological approach
Objective: To determine an optimal cutoff point of the MoCA for cognitive impairment detection in Mexican persons with PD. Background: Cognitive impairment (CI) is frequent…Levodopa Carbidopa Intestinal Gel in Patients with Deep Brain Stimulation in Parkinson’s disease- First case series from Middle-East Region
Objective: The objective is to report unique and challenging cases, who had successful control of Parkinson’s disease (PD) symptoms with combination therapy of Deep Brain…Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease
Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial
Objective: This study aimed to assess the efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease (PD) patients with motor fluctuation. Background: Delayed…The clinical challenge of an unilateral abnormal uptake in datscan
Objective: Characterize patients with unilateral abnormal uptake in DaTscan. Background: Presynaptic dopamine transporter (DaT) single-photon emission computed tomography (SPECT) imaging is the most used imaging…Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis
Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…Bullous skin lesions following introduction of safinamide in a woman with Parkinson’s disease
Objective: To present the case of a woman with Parkinson’s disease (PD) who developed pemphigoid-like skin lesions after being started on safinamide therapy. Background: Safinamide…A randomized controlled trial comparing the efficacy and safety of pyridostigmine versus midodrine for the treatment of orthostatic hypotension in Parkinson’s disease patients
Objective: To assess the long-term efficacy and safety of pyridostigmine and midodrine in the treatment of OH in PD. Background: In Parkinson's disease (PD), orthostatic…Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson´s Disease: An Open-label Prospective Study
Objective: The aim of this study was to analyze the effectiveness of opicapone on global non-motor symptoms (NMS) burden in Parkinson´s disease (PD). Background: Some…
- « Previous Page
- 1
- …
- 264
- 265
- 266
- 267
- 268
- …
- 338
- Next Page »